Common Equity: The sum of all common equity items.
Ocular Therapeutix, Inc. (OCUL) had Common Equity of $520.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$13.47M |
|
$-78.76M |
|
$2.01M |
|
$11.46M |
|
$95.58M |
|
$-82.11M |
|
$3.35M |
|
$-78.76M |
|
$-78.76M |
|
$-78.76M |
|
$-78.76M |
|
$-78.76M |
|
$-78.76M |
|
$-82.11M |
|
$-80.26M |
|
224.95M |
|
224.95M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$644.43M |
|
$19.46M |
|
$26.89M |
|
$671.32M |
|
$49.17M |
|
$72.80M |
|
$102.10M |
|
$151.28M |
|
|
Common Equity |
$520.04M |
$520.04M |
|
$520.04M |
|
219.59M |
|
| Cash Flow Statement Financials | |
$-133.26M |
|
$-8.03M |
|
$2.88M |
|
$738.67M |
|
$600.25M |
|
$-138.42M |
|
$30.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.11 |
|
-- |
|
-- |
|
0.12 |
|
0.14 |
|
85.08% |
|
-609.34% |
|
-609.34% |
|
-- |
|
-584.51% |
|
-584.51% |
|
$-141.29M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.53 |
|
0.45 |
|
202.11 |
|
-15.15% |
|
-15.15% |
|
-11.73% |
|
-13.29% |
|
$2.37 |
|
$-0.63 |
|
$-0.59 |
|